Tamer I. Khayal, Chief Commercial Officer at TransMedics Group, Inc. (TMDX), sold 4,660 shares at $159.86 ($729K) on 2024-08-01, disclosed to the SEC on 2024-08-05.
Scheduled sale ($729k) by Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $151.80 | 114 | $17K | 2.4% |
| 2 | $152.71 | 154 | $24K | 3.2% |
| 3 | $153.81 | 483 | $74K | 10.2% |
| 4 | $153.81 | 483 | $74K | 10.2% |
| 5 | $154.86 | 510 | $79K | 10.8% |
| 6 | $154.86 | 510 |
| $79K |
| 10.8% |
| 7 | $155.69 | 380 | $59K | 8.1% |
| 8 | $155.69 | 380 | $59K | 8.1% |
| 9 | $157.00 | 124 | $19K | 2.7% |
| 10 | $157.83 | 252 | $40K | 5.5% |
| 11 | $158.88 | 240 | $38K | 5.2% |
| 12 | $159.86 | 329 | $53K | 7.2% |
| 13 | $159.86 | 329 | $53K | 7.2% |
| 14 | $161.09 | 126 | $20K | 2.8% |
| 15 | $161.99 | 116 | $19K | 2.6% |
| 16 | $163.65 | 32 | $5K | 0.7% |
| 17 | $164.98 | 84 | $14K | 1.9% |
| 18 | $166.00 | 14 | $2K | 0.3% |
| Total | $156.38 avg | 4,660 | $729K | 100% |
| Filing → |
| TMDX | SELL | 2024-12-04 | $187K | — | Filing → |
| TMDX | SELL | 2024-11-13 | $263K | — | Filing → |
| TMDX | SELL | 2024-11-05 | $179K | — | Filing → |